Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study
- PMID: 9697788
- DOI: 10.1016/s0090-4295(98)00138-1
Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study
Abstract
Objectives: To compare the discriminatory potential between prostate cancer and benign conditions of the prostate in a population-based screening study, of serum prostate-specific antigen levels (PSA) and PSA corrected for both the total prostate volume (PSA-D) and the transition zone volume (PSA-T).
Methods: In a randomized population-based screening study (Rotterdam section of the European Randomized Study of Screening for Prostate Cancer), in which 10,865 men have been screened, the biopsy results of 1202 men with PSA levels of 4 ng/mL or more were evaluated. Planimetric and prolate ellipsoid volumes of the total prostate as well as of the transition zone were measured. The measured volumes were compared with the volumes of 57 radical prostatectomy specimens through Spearman's rank correlation coefficient and agreement tests. A receiver operating characteristic (ROC) curve analysis was done of sensitivity and specificity of biopsy indications through PSA and PSA corrected for the volumes measured with transrectal ultrasound.
Results: In the 1202 men studied, 361 cases of prostate cancer were diagnosed. Both PSA-D and PSA-T showed a significantly higher area under the ROC curve (0.77 and 0.79, respectively) than PSA alone (area 0.65). There was no significant difference between PSA-D and PSA-T. The use of a PSA-D threshold value of 0. 10 ng/mL/cc would have avoided 28% of biopsies at the cost of 10% of detectable cancers. A PSA-D threshold of 0.15 ng/mL/cc would have avoided 73.8% of biopsies at the cost of not diagnosing 43.8% of detectable cancers.
Conclusions: The planimetrically obtained prostate volume showed a more favorable agreement with the radical prostatectomy volume than the prolate ellipsoid volume. The discriminatory potential of the corrected PSA value is better at predicting the results of needle biopsy of the prostate when compared with PSA alone. The use of the transition zone volume for this correction results in a higher discriminatory potential when compared to the use of the total prostate volume; however, the observed difference was not statistically significant.
Similar articles
-
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.Urology. 2002 Oct;60(4 Suppl 1):4-9. doi: 10.1016/s0090-4295(02)01896-4. Urology. 2002. PMID: 12384156
-
Prostate specific antigen density of the transition zone for early detection of prostate cancer.J Urol. 1998 Aug;160(2):411-8; discussion 418-9. J Urol. 1998. PMID: 9679889
-
Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.Int Braz J Urol. 2018 Jul-Aug;44(4):709-716. doi: 10.1590/S1677-5538.IBJU.2017.0506. Int Braz J Urol. 2018. PMID: 29697929 Free PMC article.
-
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9. J Urol. 2000. PMID: 10737484 Clinical Trial.
-
When to biopsy and when to stop biopsying.Urol Clin North Am. 2003 May;30(2):253-62, viii. doi: 10.1016/s0094-0143(02)00188-x. Urol Clin North Am. 2003. PMID: 12735502 Review.
Cited by
-
Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years.Res Rep Urol. 2021 Oct 10;13:749-757. doi: 10.2147/RRU.S331506. eCollection 2021. Res Rep Urol. 2021. PMID: 34676178 Free PMC article. Review.
-
Screening for prostate cancer.Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Cochrane Database Syst Rev. 2013. PMID: 23440794 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous